Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques.

Título

Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques.

Autor

Hui Zhang, Rong Li, Xiancai Ma, Jieyi Deng, Qier Chen, Weiwei Liu, Zhilin Peng, Yidan Qiao, Yingtong Lin, Xin He

Fecha

2021

Identificador

10.1038/s41423-021-00641-8

Fuente

Cellular & molecular immunology

Archivos

https://socictopen.socict.org/files/to_import/pdfs/ee7c79533f3a2a98246d2bed48a1db8d.pdf

Colección

Citación

Hui Zhang, Rong Li, Xiancai Ma, Jieyi Deng, Qier Chen, Weiwei Liu, Zhilin Peng, Yidan Qiao, Yingtong Lin, Xin He, “Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques.,” SOCICT Open, consulta 18 de abril de 2026, https://www.socictopen.socict.org/items/show/8747.

Formatos de Salida

Position: 16987 (18 views)